Durability of clinical benefit and biomarkers in patients with advanced non-small cell lung cancer (NSCLC) treated with sotorasib, a KRAS(G12C) inhibitor Meeting Abstract
| Authors: | Hong, D. S.; Bang, Y. J.; Barlesi, F.; Durm, G.; Falchook, G.; Govindan, R.; Dy, G.; Park, K.; Strickler, J.; Burns, T.; Kim, J.; Ang, A.; Lipford, J. R.; Ngarmchamnanrith, G.; Anderson, A.; Li, B. T. |
| Abstract Title: | Durability of clinical benefit and biomarkers in patients with advanced non-small cell lung cancer (NSCLC) treated with sotorasib, a KRAS(G12C) inhibitor |
| Meeting Title: | 2020 North America Conference on Lung Cancer |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 1 Suppl. |
| Meeting Dates: | 2020 Oct 16-17 |
| Meeting Location: | Virtual |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-01-01 |
| Start Page: | S28 |
| End Page: | S29 |
| Language: | English |
| ACCESSION: | WOS:000610079600058 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2020.10.136 |
| Notes: | Meeting Abstract: MO01.31 -- Source: Wos |
